REQUEST A DEMO
Total
USD $0.00
Search more companies

Xinjiang Baihuacun Pharma Tech Co.,Ltd (China)

Main Activities: Scientific Research and Development Services
Full name: Xinjiang Baihuacun Pharma Tech Co.,Ltd Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Xinjiang Bai Hua Cun Pharma Tech Co., Ltd is a renowned company that originated from the well-known Bai Hua Cun Restaurant. On June 26, 1996, the company was listed on the Shanghai Stock Exchange, becoming a publicly traded company of the Xinjiang Production and Construction Corps. With a history of several decades, the company is a prominent enterprise that integrates energy development, catering, information product display, and digital imaging technology. Since its establishment, Bai Hua Cun Restaurant has gained a reputation for its unique style and characteristics, enduring ups and downs over half a century. In recent years, the company has actively sought new development paths by restructuring its assets and injecting promising coal assets into the market, establishing a direction for the company's main business transformation. In the future, the company will continue to adhere to the principle of maximizing shareholder interests, fully utilizing the advantages of the Corps and the capital market resources, combining asset management with capital operation, focusing on expanding the scale of the enterprise and synchronously increasing economic benefits. The company aims to seek effective new ways for leapfrog development, strive to create a corporate culture with new characteristics in the new era, and make efforts to build Xinjiang's energy enterprise. On July 14, 2021, the company changed its Chinese name from "Xinjiang Bai Hua Cun Co., Ltd" to "Xinjiang Bai Hua Cun Pharma Group Co., Ltd."

Headquarters
No. 1, South Lane, Zhongshan Road, Urumqi City, Xinjiang Uygur Autonomous Region
Zhongshan; Guangdong; Postal Code: 830002

Contact Details: Purchase the Xinjiang Baihuacun Pharma Tech Co.,Ltd report to view the information.

Website: http://www.xjbhc.net

Basic Information
Total Employees:
Purchase the Xinjiang Baihuacun Pharma Tech Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Xinjiang Baihuacun Pharma Tech Co.,Ltd report to view the information.
Registered Capital:
Purchase the Xinjiang Baihuacun Pharma Tech Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Xinjiang Baihuacun Pharma Tech Co.,Ltd report to view the information.
Incorporation Date:
June 21, 1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
20.83%
Purchase this report to view the information.
4.42%
Purchase this report to view the information.
3.93%
Purchase this report to view the information.
3.35%
Purchase this report to view the information.
2.13%
Subsidiaries
Jiangsu Lihua Biotechnology Co., Ltd.
100%
Nanjing Baihuaxin Biomedical Technology Co., Ltd.
100%
Nanjing Huanglong Biological Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Xinjiang Baihuacun Pharma Tech Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
9.38%
Total operating revenue
9.37%
Operating profit (EBIT)
30.66%
Net Profit (Loss) for the Period
35.39%
Total assets
7.94%
Total equity
4.4%
Operating Profit Margin (ROS)
1.52%
Net Profit Margin
1.58%
Return on Equity (ROE)
0.74%
Quick Ratio
0.04%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?